微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.9% | -64.55% | 150% | 86/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.16% | -65.37% | -14.07% | 96/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.35% | -38.36% | 1450% | 77/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -0.1% | -111.24% | -101.22% | 102/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.18% | -53.73% | 144.18% | 37/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.35% | -24.38% | 52.97% | 66/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.19% | -34.04% | 146.07% | 57/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.89% | -19.09% | -94.97% | 102/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 17.68% | 126.96% | 299.1% | 4/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.43% | 23.4% | 33.43% | 54/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.32% | 65.17% | 201.82% | 30/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.1% | -17.29% | -85.88% | 107/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 7.79% | -9.63% | 116.99% | 57/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.59% | -21.79% | 78.61% | 71/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.01% | -15.19% | 51.13% | 65/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 1.33% | -89.62% | -84.57% | 103/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.62% | -62.55% | 87.8% | 44/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.59% | -61.46% | 93.67% | 60/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.37% | -60.5% | -81.5% | 44/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 12.81% | 28.1% | -44.35% | 38/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 23.02% | 222.41% | 93.28% | 3/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 11.91% | 111.17% | 98.5% | 9/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 6% | 24.74% | -40% | 8/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 10% | 80.83% | 40.06% | 50/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 7.14% | 150.53% | 26.6% | 45/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.64% | 201.6% | 17.26% | 32/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.81% | 577.46% | -13.02% | 11/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 5.53% | 93.36% | 94.04% | 81/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.85% | -31.65% | 52.41% | 81/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.87% | 14.02% | 163.38% | 83/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.71% | -47.41% | -75.17% | 72/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 2.86% | 328.8% | -31.41% | 94/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.17% | 82.1% | 154.27% | 56/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 1.64% | 583.33% | 21.48% | 73/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.35% | 28.57% | 208% | 54/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -1.25% | 89.37% | -154.59% | 97/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.29% | 5625% | 854.17% | 61/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.24% | 172.73% | -77.14% | 75/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.05% | 10400% | 108.93% | 50/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | -11.76% | 26.82% | -29500% | 100/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 0.04% | -98.2% | 112.12% | 65/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | -0.33% | 96.39% | -3400% | 64/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 0.01% | -95.65% | 100.06% | 63/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |